Similar articles for PMID: 25710454

Year	Number of Results
1998	1
1999	1
2000	1
2001	2
2002	1
2004	3
2005	2
2006	7
2007	8
2008	5
2009	6
2010	8
2011	4
2012	4
2013	2
2014	12
2015	6
2016	7
2017	5
2018	8
2019	2
2020	3
2022	4
2024	0

1

Circulating endothelial cell enumeration demonstrates prolonged endothelial damage in recipients of myeloablative allogeneic stem cell transplantation.

Beije N, Versluis J, Kraan J, Gratama JW, Sleijfer S, Cornelissen JJ. Beije N, et al. Haematologica. 2015 Jun;100(6):e246-9. doi: 10.3324/haematol.2014.121731. Epub 2015 Feb 20. Haematologica. 2015. PMID: 25710454 Free PMC article. No abstract available.

2

The release of soluble factors contributing to endothelial activation and damage after hematopoietic stem cell transplantation is not limited to the allogeneic setting and involves several pathogenic mechanisms.

Palomo M, Diaz-Ricart M, Carbo C, Rovira M, Fernandez-Aviles F, Escolar G, Eissner G, Holler E, Carreras E. Palomo M, et al. Biol Blood Marrow Transplant. 2009 May;15(5):537-46. doi: 10.1016/j.bbmt.2009.01.013. Biol Blood Marrow Transplant. 2009. PMID: 19361745 Free article.

3

Predictive value of circulating angiopoietin-2 for endothelial damage-related complications in allogeneic hematopoietic stem cell transplantation.

Ueda N, Chihara D, Kohno A, Tatekawa S, Ozeki K, Watamoto K, Morishita Y. Ueda N, et al. Biol Blood Marrow Transplant. 2014 Sep;20(9):1335-40. doi: 10.1016/j.bbmt.2014.04.030. Epub 2014 May 2. Biol Blood Marrow Transplant. 2014. PMID: 24796281 Free article.

4

Allogeneic transplantation with myeloablative FluBu4 conditioning improves survival compared to reduced intensity FluBu2 conditioning for acute myeloid leukemia in remission.

Magenau JM, Braun T, Reddy P, Parkin B, Pawarode A, Mineishi S, Choi S, Levine J, Li Y, Yanik G, Kitko C, Churay T, Frame D, Riwes MM, Harris A, Bixby D, Couriel DR, Goldstein SC. Magenau JM, et al. Ann Hematol. 2015 Jun;94(6):1033-41. doi: 10.1007/s00277-015-2349-4. Epub 2015 Mar 19. Ann Hematol. 2015. PMID: 25784222

5

Lower incidence of Bronchiolitis obliterans in allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning compared with myeloablative conditioning.

Yoshihara S, Tateishi U, Ando T, Kunitoh H, Suyama H, Onishi Y, Tanosaki R, Mineishi S. Yoshihara S, et al. Bone Marrow Transplant. 2005 Jun;35(12):1195-200. doi: 10.1038/sj.bmt.1704985. Bone Marrow Transplant. 2005. PMID: 15852024

6

New myeloablative conditioning regimen with fludarabine and busulfan for allogeneic stem cell transplantation: comparison with BuCy2.

Chae YS, Sohn SK, Kim JG, Cho YY, Moon JH, Shin HJ, Chung JS, Cho GJ, Yang DH, Lee JJ, Kim YK, Kim HJ. Chae YS, et al. Bone Marrow Transplant. 2007 Sep;40(6):541-7. doi: 10.1038/sj.bmt.1705770. Epub 2007 Jul 16. Bone Marrow Transplant. 2007. PMID: 17637692

7

Risk factor analysis for thrombotic microangiopathy after reduced-intensity or myeloablative allogeneic hematopoietic stem cell transplantation.

Nakamae H, Yamane T, Hasegawa T, Nakamae M, Terada Y, Hagihara K, Ohta K, Hino M. Nakamae H, et al. Am J Hematol. 2006 Jul;81(7):525-31. doi: 10.1002/ajh.20648. Am J Hematol. 2006. PMID: 16755559 Free article.

8

Non-bacterial infections in allogeneic non-myeloablative stem cell transplant recipients.

Narreddy S, Mellon-Reppen S, Abidi MH, Klein JL, Peres E, Heilbrun LK, Smith D, Alangaden G, Chandrasekar PH. Narreddy S, et al. Transpl Infect Dis. 2007 Mar;9(1):3-10. doi: 10.1111/j.1399-3062.2006.00172.x. Transpl Infect Dis. 2007. PMID: 17313464

9

Association between an impaired bone marrow vascular microenvironment and prolonged isolated thrombocytopenia after allogeneic hematopoietic stem cell transplantation.

Kong Y, Hu Y, Zhang XH, Wang YZ, Mo XD, Zhang YY, Wang Y, Han W, Xu LP, Chang YJ, Huang XJ. Kong Y, et al. Biol Blood Marrow Transplant. 2014 Aug;20(8):1190-7. doi: 10.1016/j.bbmt.2014.04.015. Epub 2014 May 2. Biol Blood Marrow Transplant. 2014. PMID: 24792870 Free article.

10

Myeloablative allogeneic stem cell transplantation for lymphoblastic lymphoma in Sweden: a retrospective study.

Lazarevic VLj, Remberger M, Hägglund H, Hallböök H, Juliusson G, Kimby E, Malm C, Wahlin A, Omar H, Johansson JE. Lazarevic VLj, et al. Am J Hematol. 2011 Aug;86(8):709-10. doi: 10.1002/ajh.22071. Am J Hematol. 2011. PMID: 21761436 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

91 results

Results by year